The immune microenvironment in gastric adenocarcinoma

Nat Rev Gastroenterol Hepatol. 2022 Jul;19(7):451-467. doi: 10.1038/s41575-022-00591-0. Epub 2022 Mar 14.

Abstract

Like most solid tumours, the microenvironment of epithelial-derived gastric adenocarcinoma (GAC) consists of a variety of stromal cell types, including fibroblasts, and neuronal, endothelial and immune cells. In this article, we review the role of the immune microenvironment in the progression of chronic inflammation to GAC, primarily the immune microenvironment driven by the gram-negative bacterial species Helicobacter pylori. The infection-driven nature of most GACs has renewed awareness of the immune microenvironment and its effect on tumour development and progression. About 75-90% of GACs are associated with prior H. pylori infection and 5-10% with Epstein-Barr virus infection. Although 50% of the world's population is infected with H. pylori, only 1-3% will progress to GAC, with progression the result of a combination of the H. pylori strain, host susceptibility and composition of the chronic inflammatory response. Other environmental risk factors include exposure to a high-salt diet and nitrates. Genetically, chromosome instability occurs in ~50% of GACs and 21% of GACs are microsatellite instability-high tumours. Here, we review the timeline and pathogenesis of the events triggered by H. pylori that can create an immunosuppressive microenvironment by modulating the host's innate and adaptive immune responses, and subsequently favour GAC development.

Publication types

  • Review
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adenocarcinoma* / complications
  • Epstein-Barr Virus Infections* / complications
  • Epstein-Barr Virus Infections* / metabolism
  • Gastric Mucosa / metabolism
  • Helicobacter Infections* / complications
  • Helicobacter Infections* / microbiology
  • Helicobacter pylori*
  • Herpesvirus 4, Human
  • Humans
  • Inflammation / complications
  • Stomach Neoplasms* / etiology
  • Stomach Neoplasms* / metabolism
  • Tumor Microenvironment